Nanopore–based sequencing platforms offer the potential for affordable malaria molecular surveillance in resource–limited settings to track and ultimately counteract emerging threats, such as drug resistance and diagnostic escape.

With support from the Bill and Melinda Gates Foundation and building on the success of NOMADS, NOMADS 2 is continuing to strengthen and expand the use of nanopore sequencing for malaria genomic surveillance.

This factsheet provides an overview of the NOMADS 2 project.